Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Relationship of adjuvants and swine influenza vaccine to experimental neuropathy in rabbits

Summary

Experimental neuropathy, characterized by endoneurial edema and demyelination, was induced by inoculating rabbits with a combination of Freund's complete adjuvant (FCA), gangliosides, lecithin and cholesterol. A less severe demyelinating neuropathy could be induced by treatment with FCA alone but no significant change could be elicited by injection of swine influenza vaccine (SFV) alone. When FCA was combined with gangliosides, lecithins, cholesterol and SFV, neuropathy occurred, but the changes were less severe than if these agents were used without SFV. Sera were tested for myelin basic protein (MBP) and galactocerebroside (GC) antibodies in each experimental group. Neither SFV alone nor SFV combined with Freund's complete adjuvant, gangliosides, cholesterol and lecithin evoked significant antibody titers to MBP or GC. However, rabbits inoculated with FCA, gangliosides, lecithin and cholesterol had rising titers of antibody to both MBP and GC over the 3-month experimental period. One rabbit inoculated with FCA alone had significant antibody to MBP. The findings suggest that Freund's complete adjuvant alone can induce demyelination in the peripheral nerves of rabbits and that SFV may modulate the immune response acting either as an adjuvant or suppressant in the experimental demyelinating disease.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Asbury AK (1984) The swine flu incident revisited. Ann Neurol 16:513–514

  2. 2.

    Brosnan C, Lyman WD, Tansey FA, Carter TH (1985) Quantitation of mast cells in experimental allergic neuritis. J Neuropathol Exp Neurol 44:196–203

  3. 3.

    Couch RB (1981) The effects of influenza in host defences. J Infect Dis 144:284–291

  4. 4.

    Grose C, Feorino PM (1972) Epstein-Barr virus and Guillain Barre syndrome. Lancet ii:1285–1287

  5. 5.

    Hjorth RN, Bonde GM, Piner E, Hartzell RW, Rorke LB, Rubin BA (1984) Experimental neuritis induced by a mixture of neural antigens and influenza vaccines. A possible model for Guillain Barre syndrome. J Neuroimmunol 6:1–8

  6. 6.

    Hughes RAC, Powell HC (1984) Experimental allergic neuritis: demyelination induced by P2 alone and nonspecific enhancement by cerebroside. J Neuropathol Exp Neurol 43:154–161

  7. 7.

    Hurwitz ES, Holman RC, Nelson DB, Schonberger LB (1983) National surveillance for Guillain Barre syndrome —January 1978 – March 1979. Neurology 33:150–157

  8. 8.

    Hurwitz JL, Hackett CJ (1985) Influenza-specific suppression: contribution of major viral proteins to the generation and function of T suppressor cells. J Immunol 9:179–191

  9. 9.

    Izumo S, Lington C, Wekerle H, Meyerman R (1985) A morphological study on experimental allergic neuritis mediated by T-cell lines specific for bovine P2 protein in the Lewis rat. Lab Invest 53:209–218

  10. 10.

    Jahnke U, Fischer EH, Alvord EC (1985) Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 229:282–284

  11. 11.

    Kadlubowski M, Hughes RAC (1979) Identification of the neuritogen responsible for EAN. Nature 277:140–141

  12. 12.

    Khoury SA (1977) Guillain Barre syndrome, epidemiology of an outbreak. Am J Epidemiol 107:433–438

  13. 13.

    Lampert PW (1969) Mechanism of demyelination in experimental allergic neuritis. Electron microscopic studies. Lab Invest 20:127–138

  14. 14.

    Lampert PW, Garrett RS, Powell HC (1977) Demyelination in allergic and Marek's disease virus induced neuritis. Comparative electron microscopy studies. Acta Neuropathol (Berl) 40:103–110

  15. 15.

    Langmuir AD, Bregman DJ, Kurland LT (1984) An epidemiological and clinical evaluation of Guillain-Barre syndrome following vaccination in the national influenza immunization program, United States 1976–1977. Am J Epidemiol 119:841–879

  16. 16.

    Leskawa KC, Hogan EL, Dasgupta S, Chien J-L, Erwin RE, Brostoff SW (1986) Lipid content of swine influenza and other vaccines. Lipids 21:342–346

  17. 17.

    Linington C, Izumo S, Uyemura K, Meyerman R, Wekerle H (1984) A permanent rat T-cell line that mediates experimental allergic neuritis in the rat in vivo. J Immunol 133:1946–1950

  18. 18.

    Morey MK, Wiley CA, Hughes RAC, Powell HC (1985) Autonomic nerves in experimental allergic neuritis in the rat. Acta Neuropathol (Berl) 67:75–80

  19. 19.

    Nagai Y, Homoi T, Saito E, Mitsuzawa E, Ohtani S (1976) Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett 2:107–111

  20. 20.

    Nagai Y, Ohsawa T (1974) Production of high titer antisera against sialoglycosphingolipids and their characterization using sensitized liposome. Jpn J Exp Med 44:451–464

  21. 21.

    Nagai Y, Uchid T, Takeda S, Ikuta F (1978) Restoration of activity for induction of experimental allergic neuritis by a combination of myelin basic protein, P2 and gangliosides from peripheral nerve. Neurosci Lett 8:247–254

  22. 22.

    Osebold JW (1982) Mechanism of actions by immunologic adjuvants. J Am Vet Med Assoc 181:983–987

  23. 23.

    Pearson CM (1956) Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol 91:95–101

  24. 24.

    Powell HC, Braheny SL, Myers RR, Rodriguez M, Lampert PW (1983) Early changes in experimental allergic neuritis. Lab Invest 48:332–338

  25. 25.

    Powell HC, Braheny SL, Hughes RAC, Lampert PW (1984) Antigen-specific demyelination and significance of the bystander effect in peripheral nerves. Am J Pathol 114:443–453

  26. 26.

    Raine CS, Traugott U, Farook M, Bornstein M, Norton W (1981) Augmentation of immune mediated demyelination by lipid haptens. Lab Invest 45:174–182

  27. 27.

    Reiber H, Suckling AJ, Rumsby MG (1984) The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier therapy. J Neurol Sci 63:55–61

  28. 28.

    Saida T, Saida K, Dortman SH, Silberberg DH, Sumner A, Manning M, Lisak R, Brown M (1979) Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 204:1103–1106

  29. 29.

    Schonberger LB, Bregman DJ, Sullivan-Bolynai JZ, Keenlyside RA, Ziegler DW, Retailliau HR, Eddins DL, Bryan JA (1979) Guillain Barre syndrome following vaccination in the National Influenza Immunization program, United States 1976–1977. Am J Epidemiol 110:105–123

  30. 30.

    Tansey FA, Brosnan CF (1982) Protection against experimental allergic neuritis with silica quartz dust. J Neuroimmunol 3:377–391

  31. 31.

    Waksman BH, Adams RD (1955) Allergic neuritis — an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med 102:213–234

  32. 32.

    Ziegler DW, Gardner JJ, Warfield DT, Walls HH (1983) Experimental allergic neuritis-like disease in rabbits after injection with influenza vaccines mixed with gangliosides and adjuvants. Infect Immun 42:824–830

Download references

Author information

Additional information

Supported in part by grants from the National Institute of Health NS-14162, the Veterans Administration Research Service and the Medical Research Council (UK)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Powell, H.C., Mizisin, A.P., Wiley, C.A. et al. Relationship of adjuvants and swine influenza vaccine to experimental neuropathy in rabbits. Acta Neuropathol 73, 12–18 (1987). https://doi.org/10.1007/BF00695496

Download citation

Key words

  • Allergic neuritis
  • Demyelination
  • Freund's adjuvant
  • Guillain Barre Syndrome